US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 9, 2022 (4 years ago)

Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.

What was recalled

Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.

Recalling firm
ImprimisRx NJ
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0060-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Timolol recalls

See all